Collectively, our data reveal that RUNX1-IT1 promotes breast cancer tumorigenesis through inhibiting ferroptosis via regulating IGF2BP1/GPX4 axis, providing a potential prognostic marker and therapeutic target for breast cancer. This evidence concerns the gene GPX4 and breast cancer.